Using a mobile clinic to improve treatment for opioid addiction
Official title: Implementation of Contingency Management in a Mobile Low-Threshold Buprenorphine Clinic
Funded at University of Illinois at Chicago · NIH-11056876 · Data updated 2026-11-12
This study is testing a new program that helps people with opioid addiction by providing support and medication through a mobile clinic, making it easier for those in need to get the help they deserve.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project start | April 1, 2024 |
| Project end | March 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $201,960 |
| NIH project number | 5K23DA060314-02 |
| Project ID | NIH-11056876 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals struggling with opioid use disorder who may benefit from low-threshold treatment options.
✕Less likely to help
Patients who are not dealing with opioid use disorder or those who do not require medication-assisted treatment may not benefit from this research.
What this research studies
This research focuses on implementing a contingency management program in a mobile clinic that provides low-threshold buprenorphine treatment for individuals with opioid use disorder. The approach aims to enhance access to effective behavioral health treatments alongside medication, addressing barriers that have previously limited the use of such interventions in community settings. By utilizing a mobile clinic, the research seeks to reach underserved populations and improve treatment outcomes for those struggling with addiction. The project will also involve training the principal investigator in implementation science and clinical trial design to ensure the program's effectiveness.
Why it matters
Potential benefit: If successful, this research could significantly improve access to effective treatment for opioid addiction, potentially reducing overdose deaths.
How similar studies have gone: Previous research has shown that contingency management is effective in treating substance use disorders, indicating a strong potential for success in this adapted approach.
Where this research is happening
-
University of Illinois at Chicago
Chicago, United States Active
Researchers
- Principal investigator: Messmer, Sarah — University of Illinois at Chicago
- Study coordinator: Messmer, Sarah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.